Triad Rx, Inc – FDA Warning Letter Response, May 3, 2023

Record Details

This WARNING LETTER RESPONSE record concerns Triad Rx, Inc, with an inspection on May 3, 2023, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Triad Rx, Inc
Inspection date: May 3, 2023
Product type: Drugs
Office: Office of Pharmaceutical Quality
People: Ronda R. Lloyd-Jones (Director of Compliance Branch)
Matt Mcdonald

View Company Profile

ID · 36ae299e-a7c0-423a-9032-073fdeb89854

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Triad Rx, Inc

WARNING LETTER RESPONSE

Triad Rx, IncMay 3, 2023

Triad Rx, Inc – FDA Warning Letter Response, May 3, 2023

Record Details

This WARNING LETTER RESPONSE record concerns Triad Rx, Inc, with an inspection on May 3, 2023, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Triad Rx, Inc
Inspection date: May 3, 2023
Product type: Drugs
Office: Office of Pharmaceutical Quality
People: Ronda R. Lloyd-Jones (Director of Compliance Branch)
Matt Mcdonald

View Company Profile

ID · 36ae299e-a7c0-423a-9032-073fdeb89854

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Triad Rx, Inc